Collaborative Stage for TNM 7 - Revised 07/06/2011

Skin

Skin (excluding Skin of Eyelid and Malignant Melanoma, Merkel Cell Carcinoma, Kaposi Sarcoma, Mycosis Fungoides, Sezary Disease, and Other Lymphomas)

C44.0, C44.2-C44.9

CS Tumor Size
CS Extension
CS Tumor Size/Ext Eval
CS Lymph Nodes
CS Lymph Nodes Eval
Regional Nodes Positive
Regional Nodes Examined
CS Mets at DX
CS Mets Eval
CS Site-Specific Factor 1
Measured Thickness (Depth)
CS Site-Specific Factor 2 = 988
CS Site-Specific Factor 3 = 988
CS Site-Specific Factor 4 = 988
CS Site-Specific Factor 5 = 988
CS Site-Specific Factor 6 = 988
CS Site-Specific Factor 7 = 988
CS Site-Specific Factor 8 = 988
CS Site-Specific Factor 9 = 988
CS Site-Specific Factor 10
Clark Level
CS Site-Specific Factor 11
Perineural Invasion
CS Site-Specific Factor 12
High Risk Features
CS Site-Specific Factor 13 = 988
CS Site-Specific Factor 14 = 988
CS Site-Specific Factor 15 = 988
CS Site-Specific Factor 16
Size of Lymph Nodes
CS Site-Specific Factor 17 = 988
CS Site-Specific Factor 18 = 988
CS Site-Specific Factor 19 = 988
CS Site-Specific Factor 20 = 988
CS Site-Specific Factor 21 = 988
CS Site-Specific Factor 22 = 988
CS Site-Specific Factor 23 = 988
CS Site-Specific Factor 24 = 988
CS Site-Specific Factor 25 = 988
Histology Inclusion Table AJCC 7th ed.
Histology Exclusion Table AJCC 6th ed.
AJCC TNM 7 Stage
AJCC TNM 6 Stage
Summary Stage
Extension Size AJCC 6 Table
Extension Size High Risk Table
Lymph Nodes Size AJCC 7 Table
Revision Info   List of Schemas